Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.44 |
| ▸ | MAPK10 | P53779 | 6/20 | 0.43 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.41 |
| ▸ | CACNG2 | Q9Y698 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.41 |
| ▸ | FLT3 | P36888 | 2/20 | 0.39 |
| ▸ | MET | P08581 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.37 |
| ▸ | BMX | P51813 | 1/20 | 0.36 |
| ▸ | AKT1 | P31749 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13999918 | 0.94 | ESR1 (0.46) | ESR1ESR2MAPK10GRIA1CACNG8 | |
| SCHEMBL14000009 | 0.91 | ESR1 (0.40) | ESR1ESR2MAPK10GRIA1CACNG8 | |
| SCHEMBL14000363 | 0.90 | ESR1 (0.50) | ESR1ESR2MAPK10GRIA1CACNG8 | |
| SCHEMBL14363297 | 0.89 | ESR2 (0.46) | ESR1ESR2MAPK10GRIA1CACNG8 | |
| SCHEMBL29444793 | 0.89 | ESR1 (0.50) | ESR1ESR2MAPK10GRIA1CACNG8 | |
| SCHEMBL13098745 | 0.89 | ESR1 (0.50) | ESR1ESR2MAPK10GRIA1CACNG8 | |
| SCHEMBL338275 | 0.89 | ESR1 (0.50) | ESR1ESR2MAPK10GRIA1CACNG8 | |
| SCHEMBL24811902 | 0.88 | ESR1 (0.47) | ESR1ESR2MAPK10GRIA1CACNG8 | |
| SCHEMBL18999454 | 0.88 | ESR1 (0.41) | ESR1ESR2MAPK10GRIA1CACNG8 | |
| SCHEMBL14506133 | 0.88 | ESR1 (0.49) | ESR1ESR2MAPK10GRIA1CACNG8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2000464-A1 | NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE USING SAME | Idemitsu Kosan Co., Ltd. (JP) | 2008-12-10 | — | — | EP | disclosed |
| US-20070267970-A1 | NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2007-11-22 | — | — | US | disclosed |
| US-20070267970-A1 | NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2007-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070267970-A1 | NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVES AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME | NUDC, NUDT1, SLC43A1 | ESR1 1029/4885ESR2 2015/4885MAPK10 2323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.